- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bluebird bio Inc (BLUE)
0.5060
+0.0113(+2.02%)
Closed
After Hours
0.5000-0.0060(-1.1858%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.4895
0.5100
52 wk Range
0.4529
5.5300
BLUE Scorecard
Full Analysis
Operates with a significant debt burden
Bluebird bio Inc stock price live, this page displays NASDAQ BLUE stock exchange data. View the BLUE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bluebird bio Inc real time stock price chart below.
What Is the Bluebird bio Inc Stock Price Today?
The Bluebird bio Inc stock price today is 0.5060.
What Is the Stock Symbol for Bluebird bio Inc?
The stock symbol for Bluebird bio Inc is "BLUE."
What Stock Exchange Does Bluebird bio Inc Trade On?
Bluebird bio Inc is listed and trades on the NASDAQ stock exchange.
Is Bluebird bio Inc a Good Stock to Buy?
Determining whether Bluebird bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLUE quote. (ISIN: US09609G1004)
What Is the Bluebird bio Inc Stock Price Today?
The Bluebird bio Inc stock price today is 0.5060.
What Is the Stock Symbol for Bluebird bio Inc?
The stock symbol for Bluebird bio Inc is "BLUE."
What Stock Exchange Does Bluebird bio Inc Trade On?
Bluebird bio Inc is listed and trades on the NASDAQ stock exchange.
Is Bluebird bio Inc a Good Stock to Buy?
Determining whether Bluebird bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLUE quote. (ISIN: US09609G1004)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.48950.5100
52 wk Range
0.45295.5300
UnlockBLUE Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Analysts Sentiment
Neutral
Price Target
2.7525
Upside
+443.9723%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Bluebird bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Bluebird bio stock plunges to 52-week low of $0.46
- Investing.com
- Bluebird bio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Bluebird Bio CEO sells shares worth over $18k
- Investing.com
InvestingPro Research for Bluebird bio Inc
Gene Therapy Pionee | Bluebird Bio leads in innovative treatments for severe genetic diseases, with Lyfgenia for sickle cell disease at the forefront of its commercial pipeline |
Financial Hurdles | Explore Bluebird's journey to profitability amid revenue misses and accounting restatements, with analyst price targets ranging from $4 to $8 |
Market Potential | Delve into the substantial opportunities in gene therapy, particularly for sickle cell disease, balanced against fierce competition in the biotechnology secto |
Strategic Restructuring | Learn how Bluebird's operational expenditure reduction plan aims to achieve cash flow break-even by 2025, potentially extending its runway for product launches |
Bluebird bio Inc Company Profile
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company’s product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. Its clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.
Compare BLUE to Peers and Sector
Metrics to compare | BLUE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBLUEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −1.1x | −0.6x | |
PEG Ratio | 0.00 | 0.03 | 0.00 | |
Price/Book | 1.9x | 3.0x | 2.6x | |
Price / LTM Sales | 1.8x | 15.0x | 3.2x | |
Upside (Analyst Target) | 394.1% | 452.3% | 46.9% | |
Fair Value Upside | Unlock | 22.6% | 7.9% | Unlock |
People Also Watch
FAQ
What Is the Bluebird (BLUE) Stock Price Today?
The Bluebird stock price today is 0.506
What Stock Exchange Does Bluebird Trade On?
Bluebird is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Bluebird?
The stock symbol for Bluebird is "BLUE."
What Is the Bluebird Market Cap?
As of today, Bluebird market cap is 98.12M.
What is Bluebird Earnings Per Share?
The Bluebird EPS is -2.08.
What Is the Next Bluebird Earnings Date?
Bluebird will release its next earnings report on Nov 05, 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.